ID   COQ3_HUMAN              Reviewed;         369 AA.
AC   Q9NZJ6; B3KPX0; Q5T061; Q6P4F0; Q8IXG6; Q96BG1; Q9H0N1;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   10-MAY-2017, entry version 153.
DE   RecName: Full=Ubiquinone biosynthesis O-methyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03190};
DE   AltName: Full=3-demethylubiquinol 3-O-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};
DE            EC=2.1.1.64 {ECO:0000255|HAMAP-Rule:MF_03190};
DE   AltName: Full=Polyprenyldihydroxybenzoate methyltransferase {ECO:0000255|HAMAP-Rule:MF_03190};
DE            EC=2.1.1.114 {ECO:0000255|HAMAP-Rule:MF_03190};
DE   Flags: Precursor;
GN   Name=COQ3 {ECO:0000255|HAMAP-Rule:MF_03190}; ORFNames=UG0215E05;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-134; GLY-272
RP   AND HIS-329.
RC   TISSUE=Fetal brain;
RA   Xie Y., Mao Y.;
RT   "Isolation of full-length cDNA clones from human fetal brain cDNA
RT   library.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-329.
RC   TISSUE=Kidney;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLY-272 AND
RP   HIS-329.
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-134; GLY-272
RP   AND HIS-329.
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-369, CATALYTIC ACTIVITY, AND VARIANTS
RP   GLY-272 AND HIS-329.
RX   PubMed=10777520; DOI=10.1074/jbc.275.17.12381;
RA   Jonassen T., Clarke C.F.;
RT   "Isolation and functional expression of human COQ3, a gene encoding a
RT   methyltransferase required for ubiquinone biosynthesis.";
RL   J. Biol. Chem. 275:12381-12387(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: O-methyltransferase that catalyzes the 2 O-methylation
CC       steps in the ubiquinone biosynthetic pathway. {ECO:0000255|HAMAP-
CC       Rule:MF_03190}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + 3,4-dihydroxy-5-all-
CC       trans-polyprenylbenzoate = S-adenosyl-L-homocysteine + 3-methoxy-
CC       4-hydroxy-5-all-trans-polyprenylbenzoate. {ECO:0000255|HAMAP-
CC       Rule:MF_03190, ECO:0000269|PubMed:10777520}.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-methionine + 3-
CC       demethylubiquinone-n = S-adenosyl-L-homocysteine + ubiquinone-n.
CC       {ECO:0000255|HAMAP-Rule:MF_03190, ECO:0000269|PubMed:10777520}.
CC   -!- PATHWAY: Cofactor biosynthesis; ubiquinone biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_03190}.
CC   -!- SUBUNIT: Component of a multi-subunit COQ enzyme complex, composed
CC       of at least COQ3, COQ4, COQ5, COQ6, COQ7 and COQ9.
CC       {ECO:0000255|HAMAP-Rule:MF_03190}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03190}; Peripheral membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03190}; Matrix side {ECO:0000255|HAMAP-
CC       Rule:MF_03190}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding
CC       methyltransferase superfamily. UbiG/COQ3 family.
CC       {ECO:0000255|HAMAP-Rule:MF_03190}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF66826.1; Type=Frameshift; Positions=16, 18, 22, 26, 44, 49, 60, 363, 364; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF351615; AAN76515.1; -; mRNA.
DR   EMBL; AL136726; CAB66660.1; -; mRNA.
DR   EMBL; AK056955; BAG51832.1; -; mRNA.
DR   EMBL; AL513550; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015634; AAH15634.2; -; mRNA.
DR   EMBL; BC063463; AAH63463.1; -; mRNA.
DR   EMBL; AF193016; AAF66826.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS5042.1; -.
DR   RefSeq; NP_059117.3; NM_017421.3.
DR   UniGene; Hs.713623; -.
DR   ProteinModelPortal; Q9NZJ6; -.
DR   SMR; Q9NZJ6; -.
DR   BioGrid; 119731; 15.
DR   IntAct; Q9NZJ6; 1.
DR   STRING; 9606.ENSP00000254759; -.
DR   iPTMnet; Q9NZJ6; -.
DR   PhosphoSitePlus; Q9NZJ6; -.
DR   BioMuta; COQ3; -.
DR   DMDM; 313104241; -.
DR   EPD; Q9NZJ6; -.
DR   MaxQB; Q9NZJ6; -.
DR   PaxDb; Q9NZJ6; -.
DR   PeptideAtlas; Q9NZJ6; -.
DR   PRIDE; Q9NZJ6; -.
DR   DNASU; 51805; -.
DR   Ensembl; ENST00000254759; ENSP00000254759; ENSG00000132423.
DR   GeneID; 51805; -.
DR   KEGG; hsa:51805; -.
DR   UCSC; uc003ppk.4; human.
DR   CTD; 51805; -.
DR   DisGeNET; 51805; -.
DR   GeneCards; COQ3; -.
DR   H-InvDB; HIX0200854; -.
DR   HGNC; HGNC:18175; COQ3.
DR   HPA; HPA031273; -.
DR   HPA; HPA031274; -.
DR   MIM; 605196; gene.
DR   neXtProt; NX_Q9NZJ6; -.
DR   OpenTargets; ENSG00000132423; -.
DR   PharmGKB; PA134934287; -.
DR   eggNOG; KOG1270; Eukaryota.
DR   eggNOG; COG2227; LUCA.
DR   GeneTree; ENSGT00390000007284; -.
DR   HOVERGEN; HBG051078; -.
DR   InParanoid; Q9NZJ6; -.
DR   KO; K00591; -.
DR   OMA; HDWEKFV; -.
DR   OrthoDB; EOG091G0ICD; -.
DR   PhylomeDB; Q9NZJ6; -.
DR   TreeFam; TF314553; -.
DR   BioCyc; MetaCyc:HS05632-MONOMER; -.
DR   BRENDA; 2.1.1.114; 2681.
DR   BRENDA; 2.1.1.222; 2681.
DR   BRENDA; 2.1.1.64; 2681.
DR   Reactome; R-HSA-2142789; Ubiquinol biosynthesis.
DR   UniPathway; UPA00232; -.
DR   GenomeRNAi; 51805; -.
DR   PRO; PR:Q9NZJ6; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000132423; -.
DR   CleanEx; HS_COQ3; -.
DR   ExpressionAtlas; Q9NZJ6; baseline and differential.
DR   Genevisible; Q9NZJ6; HS.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0008425; F:2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity; IEA:InterPro.
DR   GO; GO:0044596; F:3-demethylubiquinone-10 3-O-methyltransferase activity; TAS:Reactome.
DR   GO; GO:0008689; F:3-demethylubiquinone-9 3-O-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044595; F:decaprenyldihydroxybenzoate methyltransferase activity; TAS:Reactome.
DR   GO; GO:0004395; F:hexaprenyldihydroxybenzoate methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008171; F:O-methyltransferase activity; IGI:UniProtKB.
DR   GO; GO:0006071; P:glycerol metabolic process; IGI:UniProtKB.
DR   GO; GO:0010795; P:regulation of ubiquinone biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006744; P:ubiquinone biosynthetic process; IGI:UniProtKB.
DR   HAMAP; MF_00472; UbiG; 1.
DR   InterPro; IPR029063; SAM-dependent_MTases.
DR   InterPro; IPR010233; UbiG_MeTrfase.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   TIGRFAMs; TIGR01983; UbiG; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Membrane; Methyltransferase;
KW   Mitochondrion; Mitochondrion inner membrane; Polymorphism;
KW   Reference proteome; S-adenosyl-L-methionine; Transferase;
KW   Transit peptide; Ubiquinone biosynthesis.
FT   TRANSIT       1     85       Mitochondrion. {ECO:0000255}.
FT   CHAIN        86    369       Ubiquinone biosynthesis O-
FT                                methyltransferase, mitochondrial.
FT                                /FTId=PRO_0000035926.
FT   BINDING     124    124       S-adenosyl-L-methionine.
FT                                {ECO:0000255|HAMAP-Rule:MF_03190}.
FT   BINDING     154    154       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen. {ECO:0000255|HAMAP-
FT                                Rule:MF_03190}.
FT   BINDING     175    175       S-adenosyl-L-methionine.
FT                                {ECO:0000255|HAMAP-Rule:MF_03190}.
FT   BINDING     222    222       S-adenosyl-L-methionine; via carbonyl
FT                                oxygen. {ECO:0000255|HAMAP-
FT                                Rule:MF_03190}.
FT   MOD_RES     143    143       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS4}.
FT   MOD_RES     149    149       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS4}.
FT   MOD_RES     196    196       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS4}.
FT   VARIANT     134    134       K -> E (in dbSNP:rs11548336).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_061925.
FT   VARIANT     272    272       S -> G (in dbSNP:rs6925344).
FT                                {ECO:0000269|PubMed:10777520,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_020789.
FT   VARIANT     329    329       Y -> H (in dbSNP:rs4144164).
FT                                {ECO:0000269|PubMed:10777520,
FT                                ECO:0000269|PubMed:11230166,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_020790.
FT   CONFLICT     21     21       G -> V (in Ref. 2; CAB66660).
FT                                {ECO:0000305}.
FT   CONFLICT    180    180       N -> D (in Ref. 2; CAB66660).
FT                                {ECO:0000305}.
FT   CONFLICT    287    289       PET -> LEP (in Ref. 1; AAN76515).
FT                                {ECO:0000305}.
FT   CONFLICT    321    321       N -> D (in Ref. 1; AAN76515).
FT                                {ECO:0000305}.
SQ   SEQUENCE   369 AA;  41054 MW;  B257A099D6C06A2D CRC64;
     MWSGRKLGSS GGWFLRVLGP GGCNTKAARP LISSAVYVKN QLSGTLQIKP GVFNEYRTIW
     FKSYRTIFSC LNRIKSFRYP WARLYSTSQT TVDSGEVKTF LALAHKWWDE QGVYAPLHSM
     NDLRVPFIRD NLLKTIPNHQ PGKPLLGMKI LDVGCGGGLL TEPLGRLGAS VIGIDPVDEN
     IKTAQCHKSF DPVLDKRIEY RVCSLEEIVE ETAETFDAVV ASEVVEHVID LETFLQCCCQ
     VLKPGGSLFI TTINKTQLSY ALGIVFSEQI ASIVPKGTHT WEKFVSPETL ESILESNGLS
     VQTVVGMLYN PFSGYWHWSE NTSLNYAAYA VKSRVQEHPA SAEFVLKGET EELQANACTN
     PAVHEKLKK
//
